Mechanisms of nonhomologous DNA end-joining in frogs, mice and men

被引:51
|
作者
Daza, P
Reichenberger, S
Gottlich, B
Hagmann, M
Feldmann, E
Pfeiffer, P
机构
[1] UNIV COLOGNE,INST GENET,D-50674 COLOGNE,GERMANY
[2] UNIV ZURICH,INST MOL BIOL 2,CH-8057 ZURICH,SWITZERLAND
关键词
cell extracts; DNA double-strand breaks; DNA-PK; DSB-repair; illegitimate recombination; ligation;
D O I
10.1515/bchm3.1996.377.12.775
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA end-joining, a process related to illegitimate recombination and capable of rejoining unrelated pairs of DNA ends in the absence of sequence homology, is considered the major pathway of double-strand break (DSB) repair in mammalian cells. Whole cell and nuclear extracts from three human and one mouse cell line were investigated for their capacities to promote nonhomologous DNA end-joining and their relative activities of DNA-PK, a mammalian DNA end-binding protein complex implicated in DSB-repair. The levels of DNA end-joining and the spectra of junctions of the human systems were identical with the ones of a previously described cell-free joining system derived from Xenopus laevis eggs. Due to the presence of potent 3'-5'-exonuclease activities the mouse system displayed decreased levels of DNA end-joining and larger fractions of junctions containing deletions but otherwise the basic mechanisms of junction formation appeared to be identical with the Xenopus system. DNA-PK activity was found to be equally low in the Xenopus and the mouse system but 4- to 6-fold increased in the human systems. Our results suggest that the mechanisms of DNA end-joining may be modulated by the level of exonuclease activities and/or DNA end-protecting factors but are otherwise highly conserved in vertebrate cells.
引用
收藏
页码:775 / 786
页数:12
相关论文
共 50 条
  • [31] DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus
    Dibiase, SJ
    Zeng, ZC
    Chen, R
    Hyslop, T
    Curran, WJ
    Iliakis, G
    CANCER RESEARCH, 2000, 60 (05) : 1245 - 1253
  • [32] Measuring nonhomologous end-joining, homologous recombination and alternative end-joining simultaneously at an endogenous locus in any transfectable human cell
    Hussain, Suleman S.
    Majumdar, Rahul
    Moore, Grace M.
    Narang, Himanshi
    Buechelmaier, Erika S.
    Bazil, Maximilian J.
    Ravindran, Pavithran T.
    Leeman, Jonathan E.
    Li, Yi
    Jalan, Manisha
    Anderson, Kyrie S.
    Farina, Andrea
    Soni, Rekha
    Mohibullah, Neeman
    Hamzic, Edin
    Rong-Mullins, Xiaoqing
    Sifuentes, Christopher
    Damerla, Rama R.
    Viale, Agnes
    Powell, Simon N.
    Higginson, Daniel S.
    NUCLEIC ACIDS RESEARCH, 2021, 49 (13)
  • [33] Bridging of double-stranded breaks by the nonhomologous end-joining ligation complex is modulated by DNA end chemistry
    Reid, Dylan A.
    Conlin, Michael P.
    Yin, Yandong
    Chang, Howard H.
    Watanabe, Go
    Lieber, Michael R.
    Ramsden, Dale A.
    Rothenberg, Eli
    NUCLEIC ACIDS RESEARCH, 2017, 45 (04) : 1872 - 1878
  • [34] An in vitro nonhomologous end-joining assay using linear duplex oligonucleotides
    Datta, Kamal
    Neumann, Ronald D.
    Winters, Thomas A.
    ANALYTICAL BIOCHEMISTRY, 2006, 358 (01) : 155 - 157
  • [35] XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining
    Ahnesorg, P
    Smith, P
    Jackson, SP
    CELL, 2006, 124 (02) : 301 - 313
  • [36] Influence of Werner helicase deficiency on nonhomologous end-joining in human cells
    Smith, Krissy
    Waldman, Alan S.
    FASEB JOURNAL, 2010, 24
  • [37] The role of nonhomologous end-joining components in telomere metabolism in Kluyveromyces lactis
    Carter, Sidney D.
    Iyer, Shilpa
    Xu, Jianing
    McEachern, Michael J.
    Astrom, Stefan U.
    GENETICS, 2007, 175 (03) : 1035 - 1045
  • [38] FBXW7 PROMOTES NONHOMOLOGOUS END-JOINING REPAIR AND RADIORESISTANCE
    不详
    CANCER DISCOVERY, 2016, 6 (03) : 225 - 225
  • [39] Tying up loose ends:: nonhomologous end-joining in Saccharomyces cerevisiae
    Lewis, LK
    Resnick, MA
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 451 (1-2) : 71 - 89
  • [40] SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end-joining
    Manjunath, Meghana
    Choudhary, Bibha
    Raghavan, Sathees C.
    CANCER REPORTS, 2021, 4 (03)